• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Method to Assess Interactivity of Drugs with Nonparallel Concentration Effect Relationships.评估药物与非平行浓度效应关系的相互作用的方法。
Curr Cancer Drug Targets. 2017;17(8):735-755. doi: 10.2174/1568009617666170330154054.
2
Fitting models for the joint action of two drugs using SAS.使用SAS拟合两种药物联合作用的模型。
Pharm Stat. 2008 Oct-Dec;7(4):272-84. doi: 10.1002/pst.312.
3
Interaction index and different methods for determining drug interaction in combination therapy.联合治疗中相互作用指数及确定药物相互作用的不同方法。
J Biopharm Stat. 2007;17(3):461-80. doi: 10.1080/10543400701199593.
4
Parallel dose-response curves in combination experiments.联合实验中的平行剂量反应曲线。
Bull Math Biol. 1998 Mar;60(2):197-213. doi: 10.1006/bulm.1997.0009.
5
Quantifying synergism/antagonism using nonlinear mixed-effects modeling: a simulation study.使用非线性混合效应模型量化协同作用/拮抗作用:一项模拟研究。
Stat Med. 2008 Mar 30;27(7):1040-61. doi: 10.1002/sim.3005.
6
Comparison of methods for evaluating drug-drug interaction.药物相互作用评估方法的比较
Front Biosci (Elite Ed). 2010 Jan 1;2(1):241-9. doi: 10.2741/e86.
7
Assessment of non-linear combination effect terms for drug-drug interactions.药物相互作用的非线性组合效应项评估。
J Pharmacokinet Pharmacodyn. 2016 Oct;43(5):461-79. doi: 10.1007/s10928-016-9490-0. Epub 2016 Sep 16.
8
Applying Emax model and bivariate thin plate splines to assess drug interactions.应用Emax模型和双变量薄板样条法评估药物相互作用。
Front Biosci (Elite Ed). 2010 Jan 1;2(1):279-92. doi: 10.2741/e90.
9
Mixed Beam Murine Harderian Gland Tumorigenesis: Predicted Dose-Effect Relationships if neither Synergism nor Antagonism Occurs.混合束诱导小鼠哈德氏腺肿瘤发生:若既无协同作用也无拮抗作用时的预测剂量效应关系。
Radiat Res. 2016 Dec;186(6):577-591. doi: 10.1667/RR14411.1. Epub 2016 Nov 22.
10
Drug Combinations: Tests and Analysis with Isoboles.药物组合:用等效线图进行测试与分析
Curr Protoc Pharmacol. 2016 Mar 18;72:9.19.1-9.19.19. doi: 10.1002/0471141755.ph0919s72.

引用本文的文献

1
A Quantitative Pharmacology Model of Exosome-Mediated Drug Efflux and Perturbation-Induced Synergy.外泌体介导的药物外排和扰动诱导协同作用的定量药理学模型
Pharmaceutics. 2021 Jun 30;13(7):997. doi: 10.3390/pharmaceutics13070997.
2
Pharmacodynamic Drug-Drug Interactions.药效学药物-药物相互作用。
Clin Pharmacol Ther. 2019 Jun;105(6):1395-1406. doi: 10.1002/cpt.1434. Epub 2019 Apr 26.

本文引用的文献

1
Antimicrobial combinations: Bliss independence and Loewe additivity derived from mechanistic multi-hit models.抗菌药物联合使用:源自多靶点机制模型的 Bliss 独立性和 Loewe 加和性
Philos Trans R Soc Lond B Biol Sci. 2016 May 26;371(1695). doi: 10.1098/rstb.2015.0294.
2
What is synergy? The Saariselkä agreement revisited.什么是协同作用?重新审视萨利色尔卡协议。
Front Pharmacol. 2015 Sep 1;6:181. doi: 10.3389/fphar.2015.00181. eCollection 2015.
3
Analysis of drug combinations: current methodological landscape.药物联合分析:当前方法学全景。
Pharmacol Res Perspect. 2015 Jun;3(3):e00149. doi: 10.1002/prp2.149. Epub 2015 May 20.
4
Sequential combination of decitabine and idarubicin synergistically enhances anti-leukemia effect followed by demethylating Wnt pathway inhibitor promoters and downregulating Wnt pathway nuclear target.地西他滨和伊达比星的序贯联合用药可协同增强抗白血病作用,随后使Wnt信号通路抑制剂启动子去甲基化并下调Wnt信号通路核靶点。
J Transl Med. 2014 Jun 12;12:167. doi: 10.1186/1479-5876-12-167.
5
Basic concepts in population modeling, simulation, and model-based drug development: part 3-introduction to pharmacodynamic modeling methods.群体建模、模拟和基于模型的药物研发的基本概念:第 3 部分——药效学建模方法介绍。
CPT Pharmacometrics Syst Pharmacol. 2014 Jan 2;3(1):e88. doi: 10.1038/psp.2013.71.
6
A search for interaction among combinations of drugs of abuse and the use of isobolographic analysis.滥用药物组合之间的相互作用的研究和使用等辐射分析。
J Clin Pharm Ther. 2013 Jun;38(3):190-5. doi: 10.1111/jcpt.12055. Epub 2013 Apr 3.
7
Metformin targets ovarian cancer stem cells in vitro and in vivo.二甲双胍在体外和体内靶向卵巢癌细胞干细胞。
Gynecol Oncol. 2012 Nov;127(2):390-7. doi: 10.1016/j.ygyno.2012.07.115. Epub 2012 Aug 2.
8
HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL.组蛋白去乙酰化酶抑制剂和地西他滨在弥漫性大 B 细胞淋巴瘤模型中具有高度协同作用,并与独特的基因表达和表观遗传特征相关。
Blood. 2011 Nov 17;118(20):5506-16. doi: 10.1182/blood-2011-02-336891. Epub 2011 Jul 19.
9
Lecture on the Antagonism between the Actions of Active Substances.活性物质作用之间的拮抗作用讲座
Br Med J. 1872 Nov 2;2(618):485-7. doi: 10.1136/bmj.2.618.485.
10
The application of drug dose equivalence in the quantitative analysis of receptor occupation and drug combinations.药物剂量等效性在受体占有率和药物组合的定量分析中的应用。
Pharmacol Ther. 2010 Aug;127(2):165-74. doi: 10.1016/j.pharmthera.2010.04.011. Epub 2010 May 28.

评估药物与非平行浓度效应关系的相互作用的方法。

Method to Assess Interactivity of Drugs with Nonparallel Concentration Effect Relationships.

机构信息

The Ohio State University, Columbus, OH. United States.

Optimum Therapeutics, LLC, 1815 Aston Ave STE 107, Carlsbad, CA 92008. United States.

出版信息

Curr Cancer Drug Targets. 2017;17(8):735-755. doi: 10.2174/1568009617666170330154054.

DOI:10.2174/1568009617666170330154054
PMID:28359247
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5623138/
Abstract

BACKGROUND

Commonly used methods for analyzing interactivity between drugs (e.g. synergy, antagonism) such as isobologram, combination index, and curve shift are based on the Loewe Additivity principle of dose equivalence and the inherent assumption of similar concentration- effect (C-E) including parallel curves and equal maximum effects (Emax), and therefore are not suitable for drugs with dissimilar C-E. This study describes a new method that is without this limitation and has the additional advantage of enabling statistical analysis.

METHODS AND RESULTS

The method comprises two steps. First, based on the dose equivalence principle, the experimentally obtained C-E of one drug was used to calculate the equally effective C-E of the other drug at no interactivity; the resulting two zero-interactivity C-E formed the upper and lower boundaries of Additivity Envelope. Next, 95% confidence intervals calculated from experimental data were added to Additivity Envelope to obtain Uncertainty Envelope (UE). Experimentally observed effects of drug combinations (C-Ecomb,observed) located within UE indicate additivity whereas C-Ecomb,observed located above or below UE indicate statistically significant (p<0.05) synergy or antagonism, respectively. Additional in silico studies demonstrated the shape and size of Additivity Envelope, which determines the ability to detect drug interactivity, depended on the Drug A-to-B concentration ratios and the ratios of their C-E curve shape parameter. Analyses of experimental results of combinations of drugs with nonparallel C-E and/or unequal Emax indicated UE as more versatile and provided more information, compared to earlier methods.

CONCLUSION

UE is a broadly applicable method for analysis, including statistical significance assessment, of drug interactivity.

摘要

背景

常用于分析药物相互作用(如协同作用、拮抗作用)的方法,如等效应线、合并指数和曲线移位,都是基于等效剂量的 Loewe 加和性原理和相似浓度-效应(C-E)的固有假设,包括平行曲线和平等最大效应(Emax),因此不适合具有不同 C-E 的药物。本研究描述了一种新方法,该方法没有这种限制,并且具有能够进行统计分析的额外优点。

方法和结果

该方法包括两个步骤。首先,基于等效剂量原理,用实验获得的一种药物的 C-E 来计算另一种药物在无相互作用时的等效 C-E;得到的两个零相互作用 C-E 形成加和性包络的上下限。接下来,用实验数据计算 95%置信区间并添加到加和性包络中,得到不确定性包络(UE)。位于 UE 内的药物组合的实验观察效应(C-Ecomb,observed)表明具有加和性,而位于 UE 之上或之下的 C-Ecomb,observed 则表示具有统计学意义(p<0.05)的协同作用或拮抗作用。额外的计算机模拟研究表明,加和性包络的形状和大小,决定了检测药物相互作用的能力,取决于药物 A 与 B 的浓度比及其 C-E 曲线形状参数比。对具有非平行 C-E 和/或不等 Emax 的药物组合的实验结果进行分析表明,与早期方法相比,UE 更通用,提供了更多信息。

结论

UE 是一种广泛适用于分析药物相互作用的方法,包括统计显著性评估。